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The Saccharomyces cerevisiae CDC25 gene and closely homologous genes in other eukaryotes encode guanine
nucleotide exchange factors for Ras proteins. We have determined the minimal region of the budding yeast
CDC25 gene capable of activity in vivo. The region required for full biological activity is approximately 450
residues and contains two segments homologous to other proteins: one found in both Ras-specific exchange
factors and the more distant BudS and Ltel proteins, and a smaller segment of 48 amino acids found only in
the Ras-specific exchange factors. When expressed in Escherichia coli as a fusion protein, this region of CDC25
was found to be a potent catalyst of GDP-GTP exchange on yeast Ras2 as well as human p21H-s but inactive
in promoting exchange on the Ras-related proteins Yptl and Rsrl. The CDC25 fusion protein catalyzed
replacement of GDP-bound to Ras2 with GTP (activation) more efficiently than that of the reverse reaction of
replacement of GTP for GDP (deactivation), consistent with prior genetic analysis of CDC25 which indicated
a positive role in the activation of Ras. To more directly study the physical interaction of CDC25 and Ras
proteins, we developed a protein-protein binding assay. We determined that CDC25 binds tightly to Ras2
protein only in the absence of guanine nucleotides. This higher affinity of CDC25 for the nucleotide-free form
than for either the GDP- or GTP-bound form suggests that CDC25 catalyzes exchange of guanine nucleotides
bound to Ras proteins by stabilization of the transitory nucleotide-free state.
Ras proteins, like trimeric G proteins, are active when
bound to GTP and inactive when bound to GDP (7). Activa-
tion of Ras proteins in vivo may be mediated by proteins
referred to as guanine nucleotide exchange factors (also
referred to as guanine nucleotide dissociation stimulators or
releasing factors) (7). The first such exchange factor for Ras
proteins to be identified was the CDC25 gene product of
Saccharomyces cerevisiae (10, 28). The essential function of
CDC25 is bypassed by mutations in RAS2 that stabilize or
promote the GTP-bound form of Ras2 (10, 12, 28), suggest-
ing that the major cellular function of CDC25 is to activate
normal Ras proteins. Biochemical analysis of CDC25 par-
tially purified from yeast cells indicates that it activates Ras
proteins by catalysis of GDP-GTP exchange (21).
CDC25 homologs that act upstream to activate Ras pro-
teins have been identified by genetic means in two other
eukaryotic organisms (5, 19, 30). In Schizosaccharomyces
pombe, the CDC25 homolog ste6 operates upstream of Ras
in the mating pheromone response pathway, and in Drosoph-
ila melanogaster, the CDC25 homolog SOS operates up-
stream of Ras in the developmental signaling pathway initi-
ated by the Sevenless protein tyrosine kinase (5, 19, 30).
Homologs of CDC25 have also been identified by molecular
cloning methods in mice, humans, and rats (6, 23, 29, 34).
Such conservation suggests that CDC25-type exchange fac-
tors play a central role in the control of eukaryotic Ras
signaling pathways.
Other close relatives of Ras, within the larger family of
Ras-like proteins, may also have corresponding GDP-GTP
* Corresponding author.
t Present address: Onyx Pharmaceuticals, Richmond, CA 94806.
exchange factors that share more limited homology with
CDC25. In budding yeast cells, two genes that share partial
homology with CDC25 have been identified, BUD5 and
LTEJ (11, 26, 35). Neither of these genes appears to function
in the RAS pathway, but genetic analysis suggests that the
BUD5 gene product acts as a GDP-GTP exchange factor for
the yeast Rap homolog encoded by RSR1IBUD1 (1, 11). A
much closer homolog of CDC25 exists in S. cerevisiae, the
SDC25 gene (8). A C-terminal fragment of SDC25 expressed
in Escherichia coli is a potent catalyst of GDP-GTP ex-
change for yeast Ras2 and mammalian p2lHras proteins, yet
genetic analysis of SDC25 has not as yet revealed any
cellular function for SDC25 in the control of Ras activity (13,
14). Perhaps two distinct CDC25-like exchange factors in
budding yeast cells allow Ras proteins to transduce signals
from different growth stimuli.
We undertook this study to determine more precisely
which region of the lengthy CDC25 gene (1,589 codons) is
required for essential cellular function and to use this infor-
mation to test recombinant CDC25 protein fragments for
GDP-GTP exchange activity. It has been suggested, on the
basis of failure of prior attempts to obtain a biochemically
active recombinant CDC25 protein, that CDC25 may require
some other yeast proteins for GDP-GTP exchange activity
(13). However, we show in this report that CDC25 protein
produced in E. coli can catalyze GDP-GTP exchange on Ras
proteins. Furthermore, we show that this activity is specific
for Ras proteins and that CDC25 is more potent at activation
of Ras proteins than at deactivation, which was predicted
from prior genetic analysis (10, 28). Additionally, we have
developed a simple protein-protein binding assay for Ras and
CDC25 that will be useful in deciphering the regions of the
two molecules involved in their physical interaction.
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FIG. 1. Map of the different CDC25 fragments used in comple-
mentation studies. Shown below the full-length CDC25 coding
region is an enlargement of a segment containing the previously
determined minimal region (codons 877 to 1552) required for activity
in vivo (10). The lightly shaded areas represent those portions of
CDC25 that are homologous to other genes. Dark shading corre-
sponds to shared homology between Ras-specific guanine nucleotide
exchange factors encoded by CDC25, ste6, SOS, and the rodent
homologs of CDC25, the putative Rap-specific GRF encoded by the
BUD5 gene, and the LTEJ gene (5, 11, 19, 23, 26, 29, 30). Light
shading corresponds to shared homology between Ras-specific
guanine nucleotide exchange factors that is not shared with BUD5 or
LTE1. Shown below are the regions of CDC25 contained within the
different plasmids used in this report to determine more precisely
the minimal essential region of CDC25.
(This work was performed in partial fulfillment of the
requirements for a doctoral thesis at Rutgers University by
C.-C. Lai.)
MATERIALS AND METHODS
Yeast strains and complementation assays. LRA26, pro-
vided by K. Tatchell, contains the cdc25-5 allele (A4 Tot leu2
ura3 his4 cdc25-5) (25). T179-1AH (A4Ta leu2 ura3 his3
trpl ade8 cdc25::URA3 pHIS3-TPKI) was constructed by
replacing the pCDC25(TRPJ)-1 plasmid harbored within
strain TT1A-1 with a high-copy-number plasmid, pHIS3-
TPKI, containing the HIS3 and TPKJ genes (10). Transfor-
mation of yeast with DNA was performed by the lithium
acetate method, with the modification that 25 mM dithiothre-
itol or 25 mM P-mercaptoethanol was included in the trans-
formation buffers. Complementation assays were performed
as described in the footnotes to Table 1.
Plasmid constructions. Plasmids pALCDC25 and pHIS3-
TPKI were provided by M. Wigler's laboratory. Plasmids
pMCDC25-A, pMCDC25-B, pMCDC25-C, pMCDC25-E,
and pCDC25-B were constructed by appropriate modifica-
tions and insertion of restriction endonuclease fragments of
CDC25 into the polylinker region that follows the initiator
codon and HA1 epitope encoded by the ADHJ-based ex-
pression vector pAD5 (16). The restriction sites within the
CDC25 locus used were BglII and PvuII (pMCDC25-A), BclI
and PvuII (pMCDC25-B), NcoI and PvuII (pMCDC25-C),
BamHI and PvuII (pMCDC25-E), and BglII and HindIII(pCDC25-B) (Fig. 1). Plasmids pAC36, pAC3B6, pAC3C6,
pAC15, and pAC14 were constructed by polymerase chain
reaction procedures, using fragments generated with appro-
priate primers derived from the CDC25 sequence and inser-
tion into pAD5. Plasmids pGTCD-1, pGTCD-6, pGTCD-7,
and pGTCD-8 were constructed with polymerase chain
reaction-derived CDC25 fragments as indicated in Table 2
and insertion into pGEX-2T (31).
Purification of GST-CDC25 fusion proteins. Plasmids en-
coding glutathione S-transferase (GST) alone or GST-
CDC25 fusion proteins were transformed into E. coli BL21.
Induction of expression and purification of the GST fusion
proteins were performed essentially as described previously
(31) with the modification that cells were cultured at 250C,
which allowed for more efficient production of soluble forms
of the fusion proteins. The final concentration and purity of
the proteins were determined by the Bio-Rad assay and
sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis (PAGE). The apparent molecular sizes of the solu-
ble GST-CDC25 proteins ranged from 73 kDa (from
pGTCD-1) to 58 kDa (from pGTCD-8). Specific yields from
100-ml cultures ranged from 0.2 to 1.4 mg. The soluble
GST-CDC25 fusion proteins did not possess intrinsic GDP or
GTP binding properties, as judged by nitrocellulose filter
binding (9).
Guanine nucleotide dissociation assays. Recombinant Ras2
and p2lras (H-rasvall2) proteins were purified as described
previously (9). Purified Yptl protein was provided by S.
Ferro-Novick. GST-Rsrl protein was purified by standard
procedures (31) from a strain provided to us by A. Bender.
Nucleotide-free Ras2 protein was prepared by dialysis of
samples for 6 days at 4°C against Mg" -free buffer containing
50% glycerol (50 mM Tris [pH 7.5], 50 mM KCl, 1 mM
dithiothreitol). Control experiments with Ras2 proteins
bound to [3H]GDP indicated that this procedure removes up
to 70% of bound nucleotide. Ras and Ras-like proteins were
loaded with either [3H]GDP (12.4 Ci/mmol; Amersham) or
[3H]GTP (9 Ci/mmol; Amersham) essentially as described
previously (15). GDP-GTP exchange reactions were per-
formed as described in the footnote to Table 2 and legend to
Fig. 4. The amount of [3H]GDP released from Ras2 protein
was linearly proportional to the amount of added soluble
GST-CDC25 protein (from pGTCD-1) over the range tested
of 0.2 to 2 pmol, using 5-min reactions containing 25 pmol of
Ras2-GDP.
Fractionation of yeast extracts and immunoblotting of
epitope-tagged CDC25 proteins. Cultures (100 ml) of LRA26
strains transformed with plasmids expressing full-length or
deletion mutant CDC25 proteins were grown in synthetic
medium to late log phase. The cells were pelleted and
washed with ice-cold buffer E (0.3 M sorbitol, 0.1 M NaCl,
5mM MgCl2, 10mM Tris [pH 7.4]), resuspended in 500,ul of
buffer E containing 1mM phenylmethylsulfonyl fluoride and
1 mg of aprotinin per ml, and lysed with glass beads and
vortexing. The lysate was cleared by centrifugation at 1,500
x g for 10 min and then centrifuged at 15,000 x g for 15 min
to obtain the supernatant (fraction A). The pellet was resus-
pended in 300pul of buffer E with the addition of 10% Triton
X-100; after 1 h, the mixture was centrifuged as before, and
the supernatant was collected (fraction B). The remaining
pellet was resuspended in 300,ul of buffer E plus 0.5%
deoxycholate and 0.1% SDS to obtain fraction C. Fifteen
microliters of each fraction was mixed with 15,ul of 2x
sample buffer, subjected to SDS-PAGE, and transferred to
nitrocellulose paper. Immunoblotting with 12CA5 antibody
was performed as described below.
Protein-protein binding assay. Samples of 75 to 300 ng of
GST or GST-CDC25 fusion protein were diluted into 2.5 ml
of buffer B (150mM NaCl, 20mM sodium phosphate [pH
7.4]) before addition of 30 of a 50% glutathione-agarose
slurry (Sigma). The mixture was rotated at4°C for 15 min
850.--------i 000 1100 1200
877
1027
1102
1230
125L
1095
1095
EZIZ
MOL. CELL. BIOL.
 o
n
 February 25, 2014 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
CDC25-Ras PROTEIN-PROTEIN INTERACTION 1347
TABLE 1. Complementation of cdc25 alleles by expression of
CDC25 gene fragments
LEU2+ Amino acids of Suppression of Suppression of
transforming CDC25 encoded cdc25a cdc25-Sb
plasmid
pAD5 None 0/381
pALCDC25 1-1589 290/386 + + +
pMCDC25-A 877-1589 216/332 + + +
pMCDC25-C 1102-1589 230/421 + + +
pAC36 1230-1589 16/316 ++
pMCDC25-E 1256-1589 20/320 + +
pAC3B6 1300-1589 0/386 +
pAC3C6 1342-1589 0/328 -
pAC15 1095-1541 206/345 + + +
pAC14 1095-1514 0/363 -
pCDC25-B 877-1502 0/318 -
a Strain T159-5AH, harboring a cdc25::URA3 allele suppressed by a HIS3+
plasmid that overexpresses the protein kinase A gene TPKI (10), was
transformed with LEU2+ plasmids expressing the indicated fragment of
CDC25. After growth of the Leu+ His+ transformants without selection for 1
day, cells were cultured on YPD plates to obtain single colonies. The presence
of the His+ plasmid in the resultant colonies was determined by replica
plating. The stability of the His+ plasmid is expressed as the ratio of the
number of His- colonies to the total number of colonies.
b Strain LRA26 was transformed with the same plasmids, and five indepen-
dent Leu+ transformants were purified, patched onto SC-Leu plates, and
tested for growth on YPD at 36°C by replica plating.
and pelleted, and the beads were washed three times with 5
ml of buffer B. The GST- or GST-CDC25-coated beads were
resuspended in 400 Rl of buffer A containing 5 mM MgCl2, 1
,ug of nucleotide-free Ras2 protein, 1% Triton X-100, and
0.2% bovine serum albumin. The binding reaction was
rotated at 4°C for 30 min, and the beads were then pelleted
and washed three times with 5 ml of buffer B containing 1%
Triton X-100. Fifteen microliters of sample buffer was added
to the washed and pelleted beads; eluted proteins were then
separated by SDS-PAGE and electrophoretically transferred
to nitrocellulose paper. Ras2 protein was detected by blot-
ting with anti-Ras antibody (DuPont) and reagents from the
ECL kit (Amersham).
RESULTS
Minimal region of CDC25 required for activity in vivo.
Previously it has been reported that of the 1,589 amino acids
encoded by CDC25, expression of a region spanning codons
877 to 1552 sufficed for essential function (10), yet the
reported areas of significant homology between CDC25 and
genes encoding other putative Ras-specific GDP-GTP ex-
change factors such as SOS are considerably smaller, com-
prising codons 1121 to 1540 (Fig. 1). This finding suggested
to us that the minimal region of CDC25 required for activity
in vivo might be smaller than the previously determined
region of codons 877 to 1552. To test this possibility, we
constructed plasmids that used the ADHI promoter to
express various fragments of the CDC25 gene and examined
the ability of these plasmids to complement both a temper-
ature-sensitive cdc25 allele (cdc25-5) and a null allele
(cdc25::URA3) (10, 25). We found that expression of regions
corresponding to either codons 1102 to 1589 or codons 1095
to 1541 was sufficient for full complementation of both alleles
(Table 1), demonstrating that the minimal region of CDC25
required for full activity in vivo is no larger than codons 1102
to 1541. This region corresponds closely to the region of
homology shared between CDC25 and other Ras-specific
GDP-GTP exchange factors (Fig. 1).
More extensive deletions of the C-terminal portion of this
smaller region of CDC25 resulted in complete loss of activity
(Table 1). However, more extensive deletions of the N-ter-
minal portion of this region resulted in only partial loss of
activity (Table 1). Expression of a fragment encoding amino
acids 1230 to 1589 still retained the ability to weakly com-
plement both cdc25-5 and cdc25::URA3, and expression of a
segment corresponding to codons 1300 to 1589 was unable to
complement cdc25:: URA3 but weakly complemented
cdc25-5 (Table 1). A more extensive deletion of the N-ter-
minal portion, which removed codons 1300 to 1341, resulted
in complete loss of activity (Table 1). We conclude that a
region of no larger than 1300 to 1541 suffices for residual
activity in vivo. This region corresponds closely to the only
homologous region between CDC25 and the putative Rap
GDP-GTP exchange factor encoded by BUD5 (Fig. 1).
One possible explanation for the failure of smaller CDC25
fragments to complement cdc25 mutations is that the corre-
sponding CDC25 mutant proteins were not expressed at
reasonable levels, or that they did not localize properly to
their normal site of action. We analyzed the expression
levels and subcellular fractionation profiles of full-length and
different deletion mutants of CDC25 that affected residues N
terminal to position 1342. By immunoblotting, full-length
CDC25 was detected almost exclusively in the particulate
fraction, suggesting membrane localization (Fig. 2A). We
observed that CDC25 was resistant to solubilization with the
nonionic detergent Triton X-100 but that it could be solubi-
lized with ionic detergents (Fig. 2A). These findings are in
agreement with a previous report that analyzed endogenous
CDC25 protein in wild-type cells (18). Of potential biological
significance, but irrelevant to the issue at hand, we found
that the level of expression of full-length CDC25 was con-
siderably lower than that of any of the deletion mutants that
lacked residues 1 to 877 (Fig. 2B). We did not observe any
significant differences in the expression levels of biologically
active CDC25 deletion mutants and biologically inactive
CDC25 deletion mutants (Fig. 2C). We also observed that
both biologically active and inactive CDC25 deletion mutant
proteins were predominantly localized to the particulate
fraction (Fig. 2C). We conclude that those deletions affecting
residues 877 to 1342 that impair the biological activity of
CDC25 do not do so by affecting the levels of expression or
cellular localization of CDC25. We have not done compara-
ble analysis on deletions affecting C-terminal residues 1510
to 1589.
Minimal region of CDC25 required for activity in vitro.
Having more precisely determined the minimal region of
CDC25 required for full and partial activity in vivo, we
wished to evaluate the ability of corresponding CDC25
fragments expressed in E. coli to stimulate GDP-GTP ex-
change on Ras2 protein. For this purpose, we constructed
bacterial expression plasmids that direct the synthesis of
CDC25 fragments fused to the GST gene (31). As shown in
Table 2, we detected Ras2-GDP-releasing activity with a
GST fusion protein that contained amino acids 1084 to 1589
of CDC25, which demonstrates that CDC25 protein by itself
can function as a GDP-GTP exchange factor. Somewhat
surprisingly, we could not detect any activity with smaller
fusion proteins that corresponded to fragments that retained
partial biological activity in yeast cells (Table 2). This
observation does not appear to be due to limitations of our
exchange assay, as when we increased the amount of the
smaller GST-protein containing residues 1300 to 1589 five-
fold and extended the exchange reaction to 20 min, we still
did not observe any activity (22). Thus, only expression of
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TABLE 2. Guanine nucleotide-releasing activities of different
GST-CDC25 fusion proteins
Amino acids of Relative amt of [3H]-GDPPlasmid CDC25 encoded remaining bound to Ras2protein (%)
pGEX-2T None 100
pGTCD-1 1084-1589 35
pGTCD-6 1189-1589 101
pGTCD-7 1230-1589 103
pGTCD-8 1300-1589 100
a Ras2 protein (250 pmol) was equilibrated for 20 min at room temperature
with an equimolar amount of [3HJGDP in 150 ml of fast-exchange buffer
(buffer A). MgCl2 was added to a final concentration of 5 mM, and after 15 min
at room temperature, the releasing assay was initiated by aliquoting 15 ml of
the Ras2-GDP mixture into tubes that contained 2.5 nmol of cold GTP plus 1
ml of the indicated GST fusion protein. After 5 min at room temperature,
duplicate samples were assayed for [3H]GDP remaining bound to Ras2 protein
by the nitrocellulose filter binding assay (9). The amounts of the various GST
fusion proteins in each assay tube were 1 to 2 pmol, relative to 25 pmol of Ras2
protein. Values are expressed as the percentage of [3H]GDP released relative
to the value for the control (GST alone).
FIG. 2. Expression levels and localization of full-length and
deleted CDC25 proteins. (A) Localization of CDC25 in yeast cells
expressing an influenza virus HA1 epitope-tagged full-length CDC25
protein. Extracts were fractionated into soluble and particulate
fractions as described in Materials and Methods and then subjected
to SDS-PAGE and immunoblotting. Lanes: 1, soluble fraction of
strain expressing epitope-tagged CDC25; 2, soluble fraction of a
control strain not expressing epitope-tagged CDC25; 3, blank; 4 and
5, Triton X-100-extractable portions of the particulate fractions of
the epitope-tagged CDC25 strain (lane 4) and the control strain (lane
5); 6, blank; 7 and 8, ionic detergent extracts of the particulate
fractions of the epitope-tagged CDC25 strain (lane 7) and the control
strain (lane 8). Shown to the left is the migration of the 200-kDa
standard. (B) Relative expression levels of full-length and N-termi-
nal deletion mutants of CDC25. Whole cell extracts of 25-ml cultures
were made by including 0.5% deoxycholate and 0.1% SDS in the
lysis buffer (see Materials and Methods), separated by SDS-PAGE,
and analyzed by immunoblotting. Lanes: 1, yeast cells carrying
pMCDC25-B (CDC25 amino acids 1027 to 1589); 2, yeast cells
carrying pMCDC25-A (CDC25 amino acids 877 to 1589); 3 and 4,
yeast cells carrying pAD5 (negative control); 5, yeast cells carrying
pALCDC25 (full-length CDC25). Shown to the right is the migration
of molecular weight standards (in kilodaltons). (C) Localization of
deletion mutant CDC25 proteins in yeast cells. Analysis was carried
out as described for panel A. Lanes: 1 to 3, yeast cells carrying
pMCDC25-A (CDC25 amino acids 877 to 1589); 4 to 6, yeast cells
carrying pMCDC25-B (CDC25 amino acids 1027 to 1589); 7 to 9,
yeast cells carrying pAC3C6 (CDC25 amino acids 1342 to 1589; 1, 4,
and 7, the Triton X-100-insoluble portion of particulate fractions; 2,
5, and 8, the Triton X-100-soluble portion of particulate fractions; 3,
6, and 9, the soluble fraction. Shown to the right is the migration of
molecular weight standards (in kilodaltons). An endogenous yeast
protein that is largely soluble, cross-reacts with the 12CA5 antibody,
and migrates slightly more slowly than the 43-kDa marker protein
was observed for all strains.
the region of CDC25 required for full activity in yeast cells
yielded a catalytically active molecule in E. coli, whereas
expression of regions corresponding to those that suffice for
weak activity in yeast cells resulted in what appears to be
completely inactive exchange factors. These shorter CDC25
fusion proteins may not fold properly in E. coli. An alterna-
tive explanation is that their partial activity in yeast cells is
due to some other property of CDC25, independent of
intrinsic exchange activity.
A significantly conserved region found only in Ras GDP-
GTP exchange factors. Our results suggested to us that
somewhere within CDC25 residues 1102 to 1300 there was a
critical determinant required for full activity in vivo and
perhaps strictly required for activity in vitro. Published
alignments of CDC25 with homologs such as SOS and BUDS
indicated that this region was homologous to the correspond-
ing region of SOS but not homologous to any regions of
BUD5 or LTE1 (5, 11, 19, 23, 26, 29, 30). We wished to
examine this matter more thoroughly and used the MACAW
multiple alignment program to analyze this region in six
Ras-specific CDC25 homologs as well as BudS and Ltel (3).
We found that the six Ras-specific homologs, but not Bud5
or Ltel, contained a significantly conserved region of 26
residues that corresponds to CDC25 residues 1143 to 1168
(Fig. 3). Immediately adjacent and N terminal to this con-
served region, we observed by eye what appears to be a
conserved extension of this region containing several amino
acid identities (Fig. 3). It should be noted, however, that we
failed to find highly significant conservation in this extension
when all six Ras-specific homologs were grouped together
and analyzed with MACAW. Downstream of this conserved
region is a larger region of highly conserved residues found
in BudS and Ltel as well as the six Ras-specific CDC25
homologs (Fig. 3). This larger conserved region, in which
four temperature-sensitive mutations of CDC25 map (25), is
likely to represent the core catalytic region of CDC25- and
BudS-type exchange factors (4). We observed that the num-
ber of residues between the N-terminal conserved region of
Ras-specific exchange factors and the more widely con-
served C-terminal region is variable, with the largest stretch
found in the rodent CDC25 homolog Ras-GRF (Fig. 3). It
should be noted that all of the active recombinant Ras
exchange factors reported to date include the N-terminal
conserved region that we have described here (13, 29).
Characterization of guanine nucleotide-releasing activity of
CDC25. Genetic analysis of CDC25 has indicated that it
functions as a positive regulator of normal Ras proteins (10,
28), and therefore one might predict that the exchange
activity of its gene product would be more potent at activa-
tion of Ras protein (promoting release of bound GDP and
replacement with GTP) than at deactivation (promoting
release of bound GTP and replacement with GDP). We
tested this prediction with the catalytically active GST-
CDC25 protein. The results displayed in Fig. 4A and B show
that under otherwise identical conditions, the recombinant
CDC25 protein was considerably more potent at catalyzing
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FIG. 3. Conserved domain specific for CDC25 homologs that act on Ras proteins. Sequences were analyzed with the multiple alignment
tool kit and MACAW program (3). (A) Schematics of eight putative exchange factors with gaps to align the homology regions; the top two
proteins (Ltel and BudS) presumably do not operate on Ras proteins themselves, whereas the bottom six have been shown genetically or
biochemically to operate on Ras proteins. The gray rectangles shared by all eight proteins represents a highly conserved region that has
recently been analyzed in detail (4). The smaller gray rectangles in the middle represent a region conserved only in the Ras-specific exchange
factors and not found in Bud5 or Ltel. (B) Amino acid sequences within the latter region. Amino acid identities are displayed by dark shading.
When all six proteins when analyzed together by MACAW, the C-terminal stretch of 26 amino acids (light shading) was the only homology
within this region found to be statistically significant. To eliminate the overestimation of statistical significance due to the substantial pairwise
similarities of CDC25/Sdc25 and murine Sos/Sos, the latter sequence from each pair was excluded from the calculations. The probability that
the aligned 26 amino acids are related by chance was calculated to be 2.1 x 10-4 (3).
replacement of bound GDP with GTP (activation) than at the
reverse reaction of replacement of bound GTP with GDP
(deactivation). Similar results have been reported for both
the SDC25 C-terminal fragment and the rodent CDC25
homolog Ras-GRF (13, 29). Our results suggest that CDC25
protein may possess a higher affinity for the GDP-bound
form of Ras2 than for the GTP-bound form (24; see Discus-
sion).
Genetic analysis of CDC25 has also indicated that its
function in yeast cells is restricted to the activation of yeast
Rasi and Ras2 proteins (10, 28), but that under certain
conditions its gene product can interact with mammalian
p2lH-ras (27). We therefore thought it possible that the
GST-CDC25 protein would act as a GDP-GTP exchange
catalyst for p2lH-ras but not for yeast members of the
Ras-like family distinct from Rasl and Ras2. To test these
possibilities, we analyzed the ability of the active GST-
CDC25 protein to promote GDP-GTP exchange for p2lH-ras,
the closely related yeast Ras-like protein Rsrl, and the more
distantly related yeast Ras-like protein Yptl (1, 33). The
results presented in Fig. 2 show that CDC25 is as potent at
catalyzing GDP-GTP exchange for human p2lH-ras as it is for
yeast Ras2. On the other hand, CDC25 failed to significantly
promote GDP-GTP exchange for the Ras-like proteins Rsrl
and Yptl (Fig. 4). We conclude that the ability of CDC25 to
act as a GDP-GTP exchange factor is specific for Ras
proteins.
Direct binding assay for CDC25 and Ras proteins. We
wished to determine whether the affinity of CDC25 for Ras
proteins was sufficiently strong so that a simple protein-
protein binding assay could be developed. Since previous
genetic results suggested that the interaction of CDC25 and
Ras2 might be more avid when Ras2 protein was nucleotide
free (26, 27), we first tested this possibility with nucleotide-
free Ras2 protein (20). We mixed CDC25 and nucleotide-free
Ras2 proteins together and then used the GST tag of the
CDC25 fusion protein to specifically absorb CDC25 with
glutathione-agarose beads. Following extensive washing, we
collected the beads and analyzed the bound proteins by
SDS-PAGE and immunoblotting with anti-Ras antibodies.
By this method, we found that Ras2 binds to the GST-
CDC25 protein but not to control GST protein (Fig. 5A). On
the basis of titration of CDC25 and comparison with a given
amount of Ras2 protein, we conclude that the binding of
CDC25 to Ras2 under these conditions is close to stoichio-
metric (Fig. 5A). The catalytically inactive CDC25 fusion
proteins, corresponding to fragments of CDC25 that had
partial biological activity in yeast cells, failed to bind to Ras2
under these conditions (Fig. 5C).
To test whether the guanine nucleotide bound state of Ras
protein influenced this tight interaction with CDC25, we
performed an experiment that examined the effect of inclu-
sion of GDP or GTP in the binding buffer, as well as the
effect of allowing binding to occur with nucleotide-free Ras2
protein but adding GDP or GTP at the washing step of the
procedure. In all cases in which guanine nucleotides were
added, either preceding or following the binding reaction, we
observed that the tight interaction between Ras2 and CDC25
protein was abolished (Fig. SB). We have also prepared
nucleotide-free Ras proteins by denaturing conditions and
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FIG. 4. Guanine nucleotide-releasing activity of GST-CDC25 fusion protein. Ras and Ras-like proteins (120 to 500 pmol) were loaded with
either [3H]GDP or [3H]GTP as described in the footnote to Table 2. The releasing reactions contained 1 ,ul of the indicated cold guanine
nucleotide plus either 1 Al of GST protein (circles) or 1 Al of GST-CDC25 protein from pGTCD-1 (boxes). At the indicated time point, the
amount of radioactive guanine nucleotide bound to Ras or Ras-like protein was determined in duplicate. Values are expressed as the
percentage of the average zero time point. (A) Each sample contained 25 pmol of Ras2, 1 pmol of GST or GST-CDC25, and 2.5 nmol of GTP.
(B) Each samyle contained 25 pmol of Ras2, 1 pmol of GST or GST-CDC25, and 2.5 nmol of GDP. (C) Each sample contained 20 pmol of
p2lras (H-ras al2), 1 pmol of GST or GST-CDC25, and 2.5 nmol of GTP. (D) Each sample contained 10 pmol of Yptl, 2 pmol of GST or
GST-CDC25, and 2.5 nmol of GTP. (E) Each sample contained 27 pmol of GST-Rsrl, 2 pmol of GST or GST-CDC25, and 2.5 nmol of GTP.
have obtained similar results (22). Since the GST-CDC25
protein itself does not bind guanine nucleotides (see Mate-
rials and Methods), this effect is likely due to alteration of
Ras2 protein conformation following its binding to guanine
nucleotides. We conclude that CDC25 possesses higher
affinity for the nucleotide-free form of Ras2 protein than for
either the GDP- or GTP-bound form.
DISCUSSION
Activation of Ras in vivo is likely to be mediated in many
cases by specific guanine nucleotide exchange factors.
Genes encoding Ras-specific GDP-GTP exchange factors all
contain a region that is structurally homologous to a portion
of the CDC25 gene of S. cerevisiae (5, 19, 23, 29, 30, 34). We
have found that expression of this homologous region of
approximately 450 codons is sufficient for complete comple-
menting activity in yeast cells and yields a catalytically
active protein when expressed in E. coli (see also references
23 and 29). Expression of a smaller C-terminal segment
within this region, spanning approximately 250 amino acids,
is sufficient for weak complementing activity in yeast cells
but fails to yield a catalytically active exchange factor when
expressed in E. coli (see also reference 23). This smaller
segment corresponds to the area of homology shared be-
tween CDC25 and putative GDP-GTP exchange factors
encoded by BUDS and LTEJ and is very likely the core
catalytic region of these exchange factors (4, 11, 26, 35).
However, this smaller segment does not contain a signifi-
cantly conserved region of 26 residues that is found in all
Ras-specific homologs of CDC25 (Fig. 3). We speculate that
this latter region is involved in the specific recognition of Ras
proteins by CDC25.
Consistent with prior genetic analysis of CDC25 which
suggested that its cellular role was restricted to Ras function,
CDC25 protein appears to interact specifically with the Ras
subgroup of the superfamily of Ras-like proteins. We and
others have determined that the ability of CDC25-type
exchange factors to catalyze GDP-GTP exchange does not
extend to other Ras-like proteins, including close relatives of
Ras within the Ral and Rap subgroups (29). It is also clear
from this and previous reports that CDC25-type exchange
factors are more potent at replacement of GDP-bound to Ras
with GTP (activation) than they are at replacement of GTP
A. Ras2 3H-GDP-+cold GTP
*1
D. Yptl 3H-GDP-+cold GTP
l
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FIG. 5. Protein-protein binding assay for Ras2 and CDC25 pro-
teins. (A) Immunoblot that detected the presence of Ras2 protein.
Lanes: 1, 200 ng of Ras2 protein as a comparative standard; 2 to 7,
samples in which 1 ,ug of nucleotide-free Ras2 protein was incubated
with glutathione-agarose beads that had been precoated with 600 ng
of GST-CDC25 (lane 2), 300 ng of GST-CDC25 (lane 3), 150 ng of
GST-CDC25 (lane 4), 75 ng of GST-CDC25 (lane 5), 75 ng of GST
alone (lane 6), or no protein (lane 7). After binding, the beads were
washed extensively and bound proteins were eluted, separated by
SDS-PAGE, and transferred to nitrocellulose paper. (B) Effect of
guanine nucleotides on CDC25-Ras2 binding. Lane 1 contains 1 pug
of Ras2 protein as a comparative standard. One microgram of
nucleotide-free Ras2 protein was incubated with glutathione-agarose
beads that had been precoated with the either 75 ng of GST protein
(lane 7) or 75 ng of GST-CDC25 protein (lanes 2 to 6). For lanes 2
and 3, the binding buffer contained no guanine nucleotides, but
either 1 mM GTP (lane 2) or 1 mM GDP (lane 3) was included in the
washing buffer. For lanes 4 and 5, the binding buffer contained either
1 mM GTP (lane 4) or 1 mM GDP (lane 5). Lane 6 represents a
control with no guanine nucleotides in the binding reaction or in the
washing buffer. (C) Inability of shorter GST-CDC25 fusion proteins
to bind to nucleotide-free Ras2. One microgram of nucleotide-free
Ras2 protein was incubated with glutathione-agarose beads that had
been precoated with 200 ng of the GST-CDC25 protein containing
CDC25 amino acids 1300 to 1589 (lane 1), 200 ng of the GST-CDC25
protein containing CDC25 amino acids 1230 to 1589 (lane 2), 200 ng
of the GST-CDC25 protein containing CDC25 amino acids 1189 to
1589 (lane 3), 200 ng of the GST-CDC25 protein containing CDC25
amino acids 1084 to 1589 (lane 4), or 200 ng of GST protein as a
negative control (lane 5). After binding, the beads were treated and
analyzed as described for panel A.
with GDP (deactivation) (13, 29). This finding confirms prior
genetic analysis of CDC25 that indicated a positive role in
the activation of Ras proteins (10, 28).
Results obtained with a genetic two-hybrid system (24),
similar to the method developed by Fields and Song (17),
indicated that CDC25 protein possesses higher affinity for
the GDP-bound form of Ras2 protein than for the GTP-
bound form. Such differential affinity may underlie the
inefficiency of CDC25 protein in catalyzing release of GTP-
bound to Ras2 protein, relative to its ability to catalyze
release of bound GDP. Additionally, with the in vivo two-
hybrid system, the Ras2Ma-22 mutant protein was found to be
more effective at interaction with CDC25 than was wild-type
Ras2 (24). We have previously reported that Ras2Ara 22
protein is seriously impaired in its ability to bind guanine
nucleotides (26), and it therefore is likely to spend more time
in vivo in a nucleotide-free state.
This latter result is consistent with the findings that we
have made by using an in vitro binding assay. We have found
that nucleotide-free Ras proteins bind tightly to CDC25
protein in a coprecipitation assay. The addition of either
GDP or GTP reverses this tight association, demonstrating
that CDC25 possesses higher affinity for the nucleotide-free
form of Ras than for either the GDP- or GTP-bound form.
Although it is unlikely that normal Ras proteins spend an
appreciable amount of time in the nucleotide-free state in
vivo, our results are consistent with a model for CDC25
action that postulates catalysis of GDP-GTP exchange by
stabilization of (higher affinity for) the transitional nucleoti-
de-free state of Ras. Such a mechanism has been proposed to
explain catalysis of GDP-GTP exchange-mediated by rho-
dopsin on the trimeric G-protein transducin (32).
It has been shown that another Ras-like protein, Ranl, is
tightly bound to its exchange factor, Rccl, in vivo (2).
Presumably this tight interaction observed in vivo is between
the GDP-bound form of Ranl with Rccl (2). No such tight
binding between the GDP-bound form of Ras2 with CDC25
was observed in this study, indicating that there may be
important differences in the mechanisms by which different
GDP-GTP exchange factors catalyze exchange on their
respective Ras-like proteins.
The direct binding assay that we have developed will be
useful in determining the regions of Ras and CDC25 that are
involved in their physical association. Additionally, it may
now be possible to isolate novel CDC25-type factors for Ras
proteins, on the basis of the tight affinity of nucleotide-free
Ras proteins for such GDP-GTP exchange factors.
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